PSMA‐heterogeneity in metastatic castration‐resistant prostate cancer: Circulating tumor cells, metastatic tumor burden, and response to targeted radioligand therapy

Thorsten Derlin(Heart and Diabetes Center North Rhine-Westphalia), Frank M. Bengel(Medizinische Hochschule Hannover)
The Prostate
May 5, 2023
Cited by 28


Related Papers